Article
Mutations in the EGFR: the importance of genotyping.
Cancer biology & therapy - 1 May 2004
Price Douglas K, Figg William D
Abstract excerpt
Gefitinib reached the clinic with anticipation, but initial clinical trials were disappointing with only a small number of patients showing response to treatment. In two recent articles published simultaneously, Lynch et al., and Paez et al. help to explain those initial clinical findings. Both groups report that somatic mutations found within the coding region of the EGFR may predict the sensitivity to gefitinib...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
